Abstracts

Search by keyword or author name.

Showing 852 abstracts.

Prashan Malhotra, M.D., L. Pompucci, Ph.D., Rahul Jain, Helena Schmidtmayerova, Ph.D. Plasma levels of b-chemokines do not associate with vertical transmission of HIV-1. Presented at: 44th Infectious Diseases Society of America Annual Meeting.

Conference

44th Infectious Diseases Society of America Annual Meeting
Yvonne J.K. Edwards, Margaret McManus, Eric R. Weiss, Eric Mick, Katherine Luzuriaga, PACTG 356 Investigators. Plasma proteomic profiles in HIV-1 infected children with and without viral control. Presented at: CROI 2018.

Conference

CROI 2018
Kumud K. Singh, Michael Hughes, Ph.D., Jie (Ellen) Chen, M.S., Stephen A. Spector, M.D. Polymorphisms in the gene encoding for CX3CR1 are important determinants of HIV-1 related disease progression of children. Presented at: 11th Conference on Retroviruses and Opportunistic Infections.

Conference

11th Conference on Retroviruses and Opportunistic Infections
John Sabo, M.S., Pedro E. Cahn, M.D., Marinella Della Negra, Ph.D., Guido Castelli-Gattinara, Claudia Fortuny, Ram Yogev, M.D., Juan Carlos Salazar, M.D., M.P.H., Chan-Loi Yong, Jaromir Mikl, Ante Jelaska, M.D. Population pharmacokinetic (PK) assessment of systemic steady-state tipranavir (TPV) concentrations for HIV+ pediatric patients administered tipranavir/ritonavir (TPV/r) 290/115 mg/m^2 and 375/150 mg/m^2 BID (BI 1182.14 and PACTG 1051 study team). Presented at: 13th Conference on Retroviruses and Opportunistic Infections.

Conference

13th Conference on Retroviruses and Opportunistic Infections

Study

P1051
M. L. Rizk, L. Du, L. Wenning, C. Bennetto-Hood , E. P. Acosta Merck & Co., Inc. Population Pharmacokinetic Analysis of Raltegravir Pediatric Formulations in HIV-infected Children 4 weeks to 18 years of Age. Presented at: ICAAC 2014.

Conference

ICAAC 2014

Study

P1066
Kensuke Shoji, Brookie M. Best, Mark Mirochnick, Alice Stek, Jiajia Wang, Tim R. Cressey, David Shapiro, Edmund V. Capparelli for IMPAACT P1026s. Population Pharmacokinetic Assessment of Factors Associated with Tenofovir Clearance in Pregnant and Postpartum Women with HIV infection in IMPAACT P1026s. Presented at: ICAAC 2015.

Conference

ICAAC 2015

Study

P1026S
Hardik Chandasana, Sven van Dijkman, Rashmi Mehta, Mark Bush, Helena Rabie, Patricia Flynn, Tim R. Cressey, Edward Acosta, Jennifer Kiser, Kristina M. Brooks. Population Pharmacokinetic Modeling of FDC DTG/ABC/3TC to Support Dosing in Children with HIV-1. Presented at: CROI 2024; 2024 Mar 05.

Conference

CROI 2024

Study

IMPAACT 2019
Population Pharmacokinetics (PK) of Lopinavir During Pregnancy and Postpartum. Presented at: IDSA IDWeek.

Conference

IDSA IDWeek

Study

P1026S
Edmund Capparelli, Pharm.D., James D. Connor, M.D., Janet Ailene Englund, M.D., Carol J. Baker, M.D., Claire Raskino, M.S., Paul Palumbo, M.D., Stephen A. Spector, M.D. Population Pharmacokinetics and Pharmacodynamics Of Dideoxynosine (ddl) In Children With HIV Infection.
Jeremiah D. Momper, Steven Sun, Mina Nikanjam, Mark Mirochnick, Kathleen M. Powis, Alice Stek, Kristina M. Brooks, Brookie M. Best, Edmund V. Capparelli. Population Pharmacokinetics of Bictegravir in Pregnant and Postpartum Persons Living with HIV. Presented at: American College of Clinical Pharmacology.

Conference

American College of Clinical Pharmacology

Study

IMPAACT 2026